Essity Aktiebolag (publ) is a multinational hygiene and health company providing essential daily-use products across consumer retail, business-to-business, and healthcare channels. Spun off as an independent publicly traded company from SCA in 2017, Essity operates across four primary business segments: Consumer Tissue, Professional Hygiene, Personal Care, and Health & Medical. In FY2025, Essity generated net sales of SEK 138.5 billion.
By product category, Consumer Tissue represents approximately 31–32% of total sales, Professional Hygiene accounts for 26%, Personal Care (including retail incontinence, feminine care, and baby care) contributes 23%, and Health & Medical (medical solutions and healthcare incontinence) generates 20%. By sales channel, retail trade accounts for roughly 54% of net sales, business-to-business represents 26%, and the healthcare sector comprises 20%. Geographically, Europe is the company's largest region, accounting for approximately 61% of net sales, followed by Latin America at 17%, North America at 16%, and Asia/Other at 6%.
Essity's portfolio features world-leading brands including TENA (incontinence care), Tork (away-from-home professional hygiene and dispensing systems), Leukoplast, Cutimed, and JOBST (wound care, orthopedics, and compression therapy), alongside regional consumer staples such as Libero, Libresse, Bodyform, Saba, Nosotras, Lotus, Tempo, and Zewa. The company holds the number one or two market position in categories representing approximately 90% of its branded sales. Following the 2024 divestment of its controlling stake in Asian tissue maker Vinda, Essity has focused capital allocation toward higher-margin medical, personal care, and premium hygiene solutions.
